PETALUMA, Calif., Sept. 20, 2011 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective healthcare products, announced today that the company has licensed the exclusive global rights to a unique endotracheal tube (ETT) from the National Institutes of Health.
